Drug Law Weekly

Canadian Brain Tumour Consortium - Canadian tumor group actively researching promising drugs

Cardiff University - Vector toxicity confounds herpes simplex virus-mediated gene delivery

Cardiome Pharma Corp. - Cardiome selects oral RSD1235 formulation

Catholic University, Rome - Effects of dietary fatty acids on insulin sensitivity reviewed

Cell Therapeutics, Inc. - Acute myeloid leukemia drug available in Japan after Nippon Shinyaku launch

Chiba University - Exogenous brain-derived neurotrophic factor may treat olfactory disorders

Chinese Academy of Sciences - Enzyme immobilization on modified PMMA microspheres characterized

Chonnam National University Hospital - Abciximab stent coating lowers risk of coronary neointimal hyperplasia

Cipla Ltd. - Stavudine formulation from India is bioequivalent to reference drug

Cleveland Clinic Foundation - Anti-TNF has good safety profiles in those with chronic viral infections

Cobalis Corp. - Company starts 6-week study as part of ongoing phase III PreHistin trial

Complementary & Alternative Medicine - Study cites possible harm from some East Indian alternative remedies

Computer Sciences Corporation - $19.7M awarded for development of biodefense vaccines

Corgentech, Inc. - Results reported from edifoligide phase III trial for peripheral bypass graft

Critical Therapeutics, Inc. - Zyflo maker reports reports Q3 net loss of $6.6 million

CuraGen Corporation - Single dose phase 1 data on drug to prevent oral mucositis presented at ASH

Cyberkinetics Neurotechnology Systems - Spaulding Rehabilitation joins BrainGate Neural Interface System pilot study

CytRx Corp. - Data shows potential of arimoclomol to reverse nerve degeneration

Cytos Biotechnology, AG - Company initiates a phase II trial with its immunodrug candidate CYT005-AllQbG10

DSM Anti-Infectives - Penicillin-products maker launches restructuring measures

Definiens - Companies announce collaboration for high-content screening applications

Diet & Nutrition - Folic acid remains public health priority

Discovery Laboratories, Inc. - Clinical data from SELECT trial presented at Hot Topics in Neonatology Meeting

Duke University - Surface agitation increases ultrasound-mediated gene transfer

Eating Disorders - Scales assessing symptoms of bulimia nervosa are sensitive to change

Erasmus Medical Center, Rotterdam - Human bone marrow stromal cells analyzed, osteogenic potential revealed

Given Imaging, Inc. - U.S. FDA OKs 14-frame PillCam ESO video capsule for the esophagus

Greystone Associates - Report: Combination-product share of drug-delivery market to approach $40B

ISTA Pharmaceuticals, Inc. - FDA approves single-use vial of Vitrase for use as spreading agent

Icagen, Inc. - Positive results reported from ICA-17043 phase II trial in sickle cell anemia

Legal Issues - Family planning group sues to halt conflicting abortion laws

Long Island Jewish Medical Center - Doctors link common chemotherapy drug to jawbone necrosis

Mentor Corp. - U.S. FDA schedules advisory hearing for silicone-gel-filled breast implant PMA

PTC Therapeutics, Inc. - Biopharma company announces orphan drug designation for PTC124

Proxima Therapeutics - Australia and New Zealand MammoSite distributor announced

Roche - New drug application submitted to FDA for intravenous injection of Boniva

Savient Pharmaceuticals, Inc. - U.S. FDA grants approval for drug to treat pain in osteoarthritis of the knee

U.S. BioDefense, Inc. - Defense contractor signs NIH agreement to evaluate virus inactivation method

U.S. Dept. of Agriculture - Regulation of Escherichia coli O157:H7 esp operon, hha and ler involved

Ventracor Limited - Bridge-to-transplant device application to be submitted to the FDA